Johnson & Johnson has rebranded with a new logo and a new name for its Janssen pharmaceutical business one year after renaming its medical device business — and just weeks after spinning off its consumer health business.
New Brunswick, New Jersey–based Johnson & Johnson (NYSE: JNJ) has replaced its 136-year-old logo — based on the signature of co-founder James Wood Johnson — with a “more modern logo and brighter red, keeping the iconic ampersand,” J&J CEO Joaquin Duato said today in a post on LinkedIn. The change is meant to call attention to J&J’s focus on innovative medicine and medtech, he said.
“Each letter is drawn in one pen stroke, creating a contrast that delivers both a sense of unexpectedness and humanity,” the company said in a news release, adding that the “refreshed, bright, and contemporary [red] speaks to the ability to urgently respond to health challenges, evolve with the times and set the pace,” while the updated ampersand “captures a caring, human nature. It now presents itself as a more globally recognizable symbol and represents the openness of the brand, as well as the connections that bring the company’s purpose to life.”
Johnson & Johnson’s old logo dated back to 1887, making it one of the longest-running corporate logos in history.
“Johnson & Johnson was founded on the principles of saving and improving lives,” company historian . “James Wood Johnson took this mission so seriously that he literally signed the family name to the company’s products.”
Johnson & Johnson just last month completed the spinoff of its consumer health brand as a new independent company called Kenvue.
Johnson & Johnson MedTech is the second-largest medtech company in the world, according to Medical Design & Outsourcing‘s latest Medtech Big 100 ranking. Janssen, meanwhile, is the world’s fourth-largest pharmaceutical company, per the Pharma 50 ranking by MDO sister publication Drug Discovery & Development.
Read more at our sister publication Medical Design & Outsourcing.